AGGX Gross Margin

The Gross Margin of Angiogenex Inc (AGGX) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

AGGX Gross Margin - Peers Comparison

Ticker	Name	Value
STLT	Spotlight Innovation Inc	-5582.51%
APPB	Applied Biosciences Corp	26.21%
BTHE	Boston Therapeutics Inc	-24304.10%
QNTA	Quanta Inc	78.70%
GLPH	Gala Pharmaceutical Inc	31.20%
CTTH	CTT Pharmaceutical Holdings Inc	7775.20%
MDCN	Medican Enterprises Inc	7775.20%
NBGV	NewBridge Global Ventures Inc	29.57%
PSIQ	Profile Solutions Inc	7775.20%
AOLS	Aeolus Pharmaceuticals Inc	7775.20%
BVXV	BiondVax Pharmaceuticals Ltd	7775.20%
CBGL	Cannabis Global, Inc.	11.25%
CNTX	Context Therapeutics Inc	7775.20%
PHBI	Pharmagreen Biotech Inc	51.03%
CDXI	Cardax Inc	63.61%
LCAR	Lescarden Inc	89.09%
PTEO	Proteo Inc	7775.20%
ACUR	Acura Pharmaceuticals Inc	100.00%
NPTX	Neuropathix Inc	100.00%
GBLX	GB Sciences Inc	6.09%
LILY.CN	Callitas Health Inc	72.61%
SNNAQ	Sienna Biopharmaceuticals Inc	7775.20%